• Title/Summary/Keyword: 바이오 마커

Search Result 208, Processing Time 0.026 seconds

Word Representation Analysis of Bio-marker and Disease Word (바이오 마커와 질병 용어의 단어 표현 분석)

  • Youn, Young-Shin;Nam, Kyung-Min;Kim, Yu-Seop
    • Annual Conference on Human and Language Technology
    • /
    • 2015.10a
    • /
    • pp.165-168
    • /
    • 2015
  • 기계학습 기반의 자연어처리 모듈에서 중요한 단계 중 하나는 모듈의 입력으로 단어를 표현하는 것이다. 벡터의 사이즈가 크고, 단어 간의 유사성의 개념이 존재하지 않는 One-hot 형태와 대조적으로 유사성을 표현하기 위해서 단어를 벡터로 표현하는 단어 표현 (word representation/embedding) 생성 작업은 자연어 처리 작업의 기계학습 모델의 성능을 개선하고, 몇몇 자연어 처리 분야의 모델에서 성능 향상을 보여 주어 많은 관심을 받고 있다. 본 논문에서는 Word2Vec, CCA, 그리고 GloVe를 사용하여 106,552개의 PubMed의 바이오메디컬 논문의 요약으로 구축된 말뭉치 카테고리의 각 단어 표현 모델의 카테고리 분류 능력을 확인한다. 세부적으로 나눈 카테고리에는 질병의 이름, 질병 증상, 그리고 난소암 마커가 있다. 분류 능력을 확인하기 위해 t-SNE를 이용하여 2차원으로 단어 표현 결과를 맵핑하여 가시화 한다.

  • PDF

Biomarkers for Canine Mammary Tumors (반려견 유선종양 바이오 마커)

  • Chan-Ho Lee;Young Sun Choi;Suk Jun Lee;Sung-Hak Kim
    • Journal of Life Science
    • /
    • v.34 no.6
    • /
    • pp.434-441
    • /
    • 2024
  • Mammary gland tumors are the most common tumors detected in non-spayed female dogs and pose a significant clinical challenge. Due to the strong similarity between canine mammary tumors (CMT) and human breast cancer (HBC), biomarkers identified in HBC can also be detected in CMT. These biomarkers have been shown to offer valuable insights into early diagnosis, prognosis, and treatment strategies. The purpose of this article is to provide a concise overview of CMT biomarkers based on the current literature. Traditional treatments for CMT in dogs typically begin with surgery, followed by chemotherapy, radiotherapy, or hormonal therapy. However, these treatments alone are not always fully effective. A diagnostic biomarker can detect the presence of a disease or the characteristics of a disease and classify an individual's status. Prognostic biomarkers focus on predicting the expected progression, recurrence, or survival of the disease in patients. By utilizing advances in understanding the mechanism of canine-specific mammary gland tumors, the estimation of biomarkers offers hope for improved outcomes in cancer patients. Novel technologies, such as single-cell RNA sequencing analysis, could provide a valuable resource for deciphering intra- and inter-tumoral heterogeneity. This review paper explores current research on CMT biomarkers and suggests directions for their development.

Biomarker Detection on Aptamer-based Biochip Data by Potential SVM (Potential SVM을 이용한 압타머칩에서의 바이오마커 탐색)

  • Kim, Byoung-Hee;Kim, Sung-Chun;Zhang, Byoung-Tak
    • Proceedings of the Korean Information Science Society Conference
    • /
    • 2006.10a
    • /
    • pp.22-27
    • /
    • 2006
  • 압타머칩은 혈청(serum) 내의 지정된 단백질의 상대적 양을 직접 측정할 수 있는 바이오칩으로서, 의학적 질병 진단에 유용하게 사용할 수 있는 툴이다. 압타머칩 데이터 분석에는 기존의 마이크로어레이 분석기법을 그대로 적용할 수 있다. 본 논문에서는 Potential SVM(PSVM)을 이용하여, 심혈관질환 샘플 기반의 압타머칩 데이터에서 바이오마커 후보 단백질을 선정한 결과를 정리한다. PSVM은 분류 알고리즘으로서 뿐만 아니라 자질 선택(feature selection)에서도 우수한 성능을 보이는 알고리즘으로 알려져 있다. 심혈관 질환의 단계에 따라 구분한 4개 클래스, 135개 샘플로 구성된 3K 압타머칩 데이터에 대해 PSVM을 적용하여 자질을 선택하고 분류성능을 측정한 결과, 마이크로어레이에서의 자질 선택에 많이 사용되는 Gain Ratio 기법과 비교하여 보다 적은 수의 단백질 정보로 보다 나은 분류 성능을 보임을 확인하였다. 더불어, PSVM을 이용해 선택한 단백질군을 심혈관 질환 진단을 위한 바이오마커 후보로 제시한다.

  • PDF

Biomarker Extraction Algorithm for Oriental Genetic Lesion (한의학적 유전병변 바이오 마커 추출 알고리즘)

  • Kim, Min-kang;Woo, Sung-hee;Cho, Young-bok
    • Proceedings of the Korean Institute of Information and Commucation Sciences Conference
    • /
    • 2019.05a
    • /
    • pp.367-371
    • /
    • 2019
  • 'Scientificization' of oriental medicine is a task to be preceded for K-MEDI in the world. Also, We are trying to secure efficacy and safety through scientifically proving the efficacy of Oriental medicine. This paper. We propose a biomarker extraction algorithm for genetic lesion reading of Oriental medicine. Also, A variety of applications in terms of Oriental medicine. Oriental medicine was suggested as a basis for the diagnosis and treatment of the treatment.

  • PDF

Diagnosis of Parkinson's Disease Using Two Types of Biomarkers and Characterization of Fiber Pathways (두 가지 유형의 바이오마커를 이용한 파킨슨병의 진단과 신경섬유 경로의 특징 분석)

  • Kang, Shintae;Lee, Wook;Park, Byungkyu;Han, Kyungsook
    • KIPS Transactions on Software and Data Engineering
    • /
    • v.3 no.10
    • /
    • pp.421-428
    • /
    • 2014
  • Like Alzheimer's disease, Parkinson's Disease(PD) is one of the most common neurodegenerative brain disorders. PD results from the deterioration of dopaminergic neurons in the brain region called the substantia nigra. Currently there is no cure for PD, but diagnosing in its early stage is important to provide treatments for relieving the symptoms and maintaining quality of life. Unlike many diagnosis methods of PD which use a single biomarker, we developed a diagnosis method that uses both biochemical biomarkers and imaging biomarkers. Our method uses ${\alpha}$-synuclein protein levels in the cerebrospinal fluid and diffusion tensor images(DTI). It achieved an accuracy over 91.3% in the 10-fold cross validation, and the best accuracy of 72% in an independent testing, which suggests a possibility for early detection of PD. We also analyzed the characteristics of the brain fiber pathways of Parkinson's disease patients and normal elderly people.

Blood Biomarkers for Alzheimer's Dementia Diagnosis (알츠하이머성 치매에서 혈액 진단을 위한 바이오마커)

  • Chang-Eun, Park
    • Korean Journal of Clinical Laboratory Science
    • /
    • v.54 no.4
    • /
    • pp.249-255
    • /
    • 2022
  • Alzheimer's disease (AD) represents a major public health concern and has been identified as a research priority. Clinical research evidence supports that the core cerebrospinal fluid (CSF) biomarkers for AD, including amyloid-β (Aβ42), total tau (T-tau), and phosphorylated tau (P-tau), reflect key elements of AD pathophysiology. Nevertheless, advances in the clinical identification of new indicators will be critical not only for the discovery of sensitive, specific, and reliable biomarkers of preclinical AD pathology, but also for the development of tests that facilitate the early detection and differential diagnosis of dementia and disease progression monitoring. The early detection of AD in its presymptomatic stages would represent a great opportunity for earlier therapeutic intervention. The chance of successful treatment would be increased since interventions would be performed before extensive synaptic damage and neuronal loss would have occurred. In this study, the importance of developing an early diagnostic method using cognitive decline biomarkers that can discriminate between normal, mild cognitive impairment (MCI), and AD preclinical stages has been emphasized.

Development of a Skin Index Using Skin Characteristic Factors and Skin Biomarkers of Korean Women According to H igh Temperature and Low Humidity Environments (고온건조 환경에 따른 한국 여성의 피부 특성인자와 피부 바이오 마커를 활용한 피부 지수 개발)

  • Jihye Maeng;Gaewon Nam
    • Journal of the Society of Cosmetic Scientists of Korea
    • /
    • v.49 no.4
    • /
    • pp.341-348
    • /
    • 2023
  • In this study, basic skin characteristic data was measured by measuring skin hydration, skin sebum secretion rate, skin melanin index, skin redness index, skin redness image analysis, transepidermal water loss (TEWL), and amount of stratum corneum before and after creating a temporary high temperature and low humidity environments targeting Korean women in their 20s to 50s. Stratum corneum by tape stripping was collected at each measurement and skin biomarkers including total protein content, carbonylated protein, neutral lipid, and lipid peroxidation were analyzed. Based on the results, the differences before and after creating a high temperature and low humidity environments were confirmed, the correlation between skin characteristics and skin biomarkers was confirmed, and a new skin index was created based on this. The new skin index can be used in product efficacy evaluation, and the possibility of constructing a new clinical study method and using skin biomarker discovery research through additional research was confirmed.

Prediction of Cognitive Impairment Using Blood Gene Expression Based on Machine Learning (혈액 유전자 발현을 이용한 기계학습 기반 인지장애 예측)

  • Lee, Seungeun;Zhou, Yu;Kang, Kyungtae
    • Proceedings of the Korean Society of Computer Information Conference
    • /
    • 2022.07a
    • /
    • pp.61-62
    • /
    • 2022
  • 알츠하이머성 치매는 현존하는 치료법이 없어 경도인지장애 단계에서의 예방이 중요하다. 지금까지의 알츠하이머 연구는 대부분이 뇌영상 마커와 뇌척수액 마커에 집중되어 있었으며, 경도 인지 장애 단계에서의 탐색은 더욱 적었다. 이러한 점에서 혈액 유전자 발현을 이용한 경도 인지장애 단계 예측은 인지 능력에 따른 관련 유전자 식별과 접근 가능한 진단 및 치료 바이오 마커 탐색에 기여할 수 있다. 그러나 유전자 발현 데이터의 경우 환자 수에 비해 높은 차원을 가지기 때문에 과적합을 막고 질병 관련 유전자를 식별하기 위해서는 데이터에서의 의미 있는 차원만을 뽑아내는 차원 축소가 선행되야 한다. 본 연구는 유전자 발현데이터에서의 인지장애 분류를 위해 차원 축소기법과 신경망을 적용하여 인지 장애 정도를 예측하였다. 그 결과, Lasso 이용 차원축소와 신경망을 이용하여 97%의 정확도로 정상과 조기 경도 인지장애, 후기 경도 인지장애 환자를 분류 할 수 있었으며, 더 적은 차원에서도 분류가 가능했다. 이는 혈액 유전자 발현을 이용해 경도 인지장애 단계를 예측한 첫 번째 연구이며, 인지능력 저하에 따른 혈액 유전자 발현의 연관성을 확인하고 향후 조기 진단, 치료 표적 탐색에 기여한다.

  • PDF

Platelets as a Source of Peripheral Aβ Production and Its Potential as a Blood-based Biomarker for Alzheimer's Disease (말초 아밀로이드 베타 원천으로서의 혈소판과 알츠하이머병의 혈액 바이오마커로서의 가능성)

  • Kang, Jae Seon;Choi, Yun-Sik
    • Journal of Life Science
    • /
    • v.30 no.12
    • /
    • pp.1118-1127
    • /
    • 2020
  • Alzheimer's disease causes progressive neuronal loss that leads to cognitive disturbances. It is not currently curable, and there is no way to stop its progression. However, since medical treatment for Alzheimer's disease is most effective in the early stages, early detection can provide the best chance for symptom management. Biomarkers for the diagnosis of Alzheimer's disease include amyloid β (Aβ) deposition, pathologic tau, and neurodegeneration. Aβ deposition and phosphorylated tau can be detected by cerebrospinal fluid (CSF) analysis or positron emission tomography (PET). However, CSF sampling is quite invasive, and PET analysis needs specialized and expensive equipment. During the last decades, blood-based biomarker analysis has been studied to develop fast and minimally invasive biomarker analysis method. And one of the remarkable findings is the involvement of platelets as a primary source of Aβ in plasma. Aβ can be transported across the blood - brain barrier, creating an equilibrium of Aβ levels between the brain and blood under normal condition. Interestingly, a number of clinical studies have unequivocally demonstrated that plasma Aβ42/Aβ40 ratios are reduced in mild cognitive impairment and Alzheimer's disease. Together, these recent findings may lead to the development of a fast and minimally invasive early diagnostic approach to Alzheimer's disease. In this review, we summarize recent advances in the biomarkers of Alzheimer's disease, especially the involvement of platelets as a source of peripheral Aβ production and its potential as a blood-based biomarker.

Heat Shock Proteins in Heat Stressed Chickens (닭의 열 스트레스와 열충격단백질)

  • Moon, Yang Soo
    • Korean Journal of Poultry Science
    • /
    • v.47 no.4
    • /
    • pp.219-227
    • /
    • 2020
  • As the earth's average temperature rises, crop and livestock productions are at risk. Chickens are sensitive to heat stress, and increased temperatures may have adverse effects on their production performance and animal welfare. Reliable stress measurements are crucial for heat stress adaptation. Therefore, various measurement methods and biomarkers are used to evaluate poultry stress levels. Heat shock proteins (HSPs) are heat sensitive biological markers that are highly expressed under stress, thereby acting as a cellular thermometer. HSPs also have chaperone activity, which protects cells from heat stress. This review details the role of HSP70 as a molecular chaperone and biomarker for heat stress, which is important for breeding climate-adaptable, thermo-tolerant poultry.